Clinical Trials
53 trialsTroFuse-036
Merck Sharp & Dohme LLC
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
National Cancer Institute (NCI)
BEATcc
Grupo Español de Investigación en Cáncer de Ovario
NELCER
Tata Memorial Hospital
KEYNOTE-A18
Merck Sharp & Dohme LLC
KEYNOTE-826
Merck Sharp & Dohme LLC
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Radiation Therapy Oncology Group
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
Akeso
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery
GOG Foundation
A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
INTERLACE
University College, London
Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline
Huazhong University of Science and Technology
AddChemo
Hospital do Coracao
A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma
Biotech Pharmaceutical Co., Ltd.
Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer
Shantou University Medical College
ONCOCOL01
University Hospital, Toulouse
QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
Qilu Pharmaceutical Co., Ltd.
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
GOG Foundation
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
Shanghai Henlius Biotech
FERMATA
Biocad
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
National Cancer Institute (NCI)
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
National Cancer Institute (NCI)
Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer
Taiho Pharmaceutical Co., Ltd.
TACO
Korea Cancer Center Hospital
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
GOG Foundation
SYSGO-003
Sun Yat-sen University
mEHT
University of Witwatersrand, South Africa
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
GOG Foundation
A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer
Sun Yat-sen University
Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer
Asan Medical Center
ACT-LACC
Navamindradhiraj University
SYSGO002
Sun Yat-sen University
Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
CERVIPIB
The National Center of Oncology, Azerbaijan
Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
Japan Clinical Oncology Group
Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients
Wenzhou Medical University
Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients
Wenzhou Medical University
Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer
Air Force Military Medical University, China
NACOPRAD
Charite University, Berlin, Germany
Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer
Korea Cancer Center Hospital
Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer
Duke University
Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
GOG Foundation
Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
GOG Foundation
Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
GOG Foundation
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
GOG Foundation
Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
SWOG Cancer Research Network
Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix
Indira Gandhi Medical College, Shimla
CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy
International Atomic Energy Agency
Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients
International Atomic Energy Agency